North Dakota House passes medical marijuana delay
A bill that would delay parts of North Dakota's new medical marijuana law awaits Gov. Doug Burgum's signature.
The House passed Senate Bill 2154 with just one dissenting vote Friday, Jan. 20. The bill would suspend provisions of the North Dakota Compassionate Care Act to give the state Department of Health more time to set up rules.
The suspension would last through July 31 or the effective date of legislation authorizing the prescription, dispensing, growth and use of medical marijuana, whichever comes first.
Lawmakers argued Friday that they were not trying to deny the will of the voters who passed the law in November, but rather sought to make sure proper regulations are put in place.
This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.
420 Intel is Your Source for Marijuana News
420 Intel Canada is your leading news source for the Canadian cannabis industry. Get the latest updates on Canadian cannabis stocks and developments on how Canada continues to be a major player in the worldwide recreational and medical cannabis industry.
420 Intel Canada is the Canadian Industry news outlet that will keep you updated on how these Canadian developments in recreational and medical marijuana will impact the country and the world. Our commitment is to bring you the most important cannabis news stories from across Canada every day of the week.
Marijuana industry news is a constant endeavor with new developments each day. For marijuana news across the True North, 420 Intel Canada promises to bring you quality, Canadian, cannabis industry news.
You can get 420 Intel news delivered directly to your inbox by signing up for our daily marijuana news, ensuring you’re always kept up to date on the ever-changing cannabis industry. To stay even better informed about marijuana legalization news follow us on Twitter, Facebook and LinkedIn.